Vigil Neuroscience, Inc.
VIGL
$1.67
-$0.10-5.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.38M | 28.01M | 28.01M | 28.08M | 27.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.68M | 88.43M | 90.07M | 89.51M | 88.87M |
| Operating Income | -89.68M | -88.43M | -90.07M | -89.51M | -88.87M |
| Income Before Tax | -84.26M | -82.60M | -83.84M | -82.78M | -82.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.26 | -82.60 | -83.84 | -82.78 | -82.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.26M | -82.60M | -83.84M | -82.78M | -82.64M |
| EBIT | -89.68M | -88.43M | -90.07M | -89.51M | -88.87M |
| EBITDA | -89.23M | -87.97M | -89.62M | -89.06M | -88.47M |
| EPS Basic | -2.07 | -2.07 | -2.12 | -2.12 | -2.13 |
| Normalized Basic EPS | -1.29 | -1.29 | -1.33 | -1.33 | -1.33 |
| EPS Diluted | -2.07 | -2.07 | -2.12 | -2.12 | -2.13 |
| Normalized Diluted EPS | -1.29 | -1.29 | -1.33 | -1.33 | -1.33 |
| Average Basic Shares Outstanding | 162.66M | 159.84M | 158.07M | 156.16M | 154.84M |
| Average Diluted Shares Outstanding | 162.66M | 159.84M | 158.07M | 156.16M | 154.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
